Stay updated with breaking news from Alpine Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vivek Ramaswamy's court case reportedly involves a dispute over a biotech buyout and investors are looking towards the GOP candidate to provide testimony.
Biotech entrepreneur and 2024 presidential candidate Vivek Ramaswamy is trying to avoid deposition in a lawsuit over a corporate deal involving Myovant Sciences | World News
He claims he doesn't have time to give a deposition in New York in a case where investors are claiming one of his companies underpaid while buying another
Multimillionaire biotech entrepreneur Vivek Ramasamy is leaning on his brisk campaign itinerary in a bid to wiggle out of deposition in a bitter biotech buyout case.
Sound familiar?